Skip to main content
. Author manuscript; available in PMC: 2014 Nov 15.
Published in final edited form as: Biol Psychiatry. 2013 May 9;74(10):760–767. doi: 10.1016/j.biopsych.2013.03.021

Table 2.

[11C]WAY-100635 PET Scan Parameters

Control Subjects
(n = 51)
Remitters
(n = 11)
Nonremitters
(n = 13)
Remitters Versus
Nonremitters p Value
Control Subjects
Versus MDD p Value
Injected Dose (mCi) 7.99 ± 3.43 5.68 ± 1.34 5.56 ± 1.62 .85 .002
Injected Mass (μg) 2.98 ± 1.94 1.30 ± 1.28 1.29 ± .95 .98 <.001
Plasma Free Fraction (fP) 8.09% ± 2.40% 6.49% ± 1.95% 6.34% ± 2.05% .85 .004
Reference Region Binding .25 ± .011 .24 ± .023 .28 ± .024 .27 .60
 (volume of distribution, VT(REF),
 Cerebellar White Matter)

MDD, major depressive disorder; PET, positron emission tomography.